Optiver Holding’s ProShares Ultra CRCL CRCA Stock Holding History

Optiver Holding’s Portfolio CRCA Stock Details CRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Buy	+91,282	New	+$3.52M	﹤0.01%	629
2026 Q1	–	Sell	-8,009	Closed	-$324K	–	2825
2025 Q4	$324K	Buy	+8,009	New	+$687K	﹤0.01%	638

Other funds holding CRCA

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Optiver Holding's CRCA Position: Q2 2026 in Review

Optiver Holding opened a new position in ProShares Ultra CRCL (CRCA) in Q2 2026: 91,282 shares worth $1.17M. The stake represents ﹤0.01% of the portfolio and ranks #629 among its holdings. This is a return to the name: Optiver Holding previously reported a position in CRCA as recently as Q4 2025.

Optiver Holding first reported a position in CRCA in Q4 2025 and has held it in 2 quarters since. 7 funds tracked by Wall St. Rank hold CRCA as of Q2 2026.

Optiver Holding held 91,282 shares of ProShares Ultra CRCL worth $1.17M as of Q2 2026.
ProShares Ultra CRCL was a new Optiver Holding position in Q2 2026.
ProShares Ultra CRCL made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #629 holding.
Optiver Holding first reported a position in ProShares Ultra CRCL in Q4 2025 and has held it in 2 quarters since.
7 funds tracked by Wall St. Rank held ProShares Ultra CRCL as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.